Details
Stereochemistry | RACEMIC |
Molecular Formula | C36H72NO8P |
Molecular Weight | 677.9325 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC
InChI
InChIKey=CITHEXJVPOWHKC-UHFFFAOYSA-N
InChI=1S/C36H72NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-35(38)42-32-34(33-44-46(40,41)43-31-30-37(3,4)5)45-36(39)29-27-25-23-21-19-17-15-13-11-9-7-2/h34H,6-33H2,1-5H3
DescriptionSources: DOI: 10.1042/bst0170713Curator's Comment: description was created based on several sources, including:
http://www.wikidoc.org/index.php/Phosphatidylcholine
http://www.ncbi.nlm.nih.gov/pubmed/4351059
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070570.pdf
Sources: DOI: 10.1042/bst0170713
Curator's Comment: description was created based on several sources, including:
http://www.wikidoc.org/index.php/Phosphatidylcholine
http://www.ncbi.nlm.nih.gov/pubmed/4351059
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070570.pdf
DMPC belongs to the synthetic phosphatidylcholines. Phosphatidylcholines are a class of phospholipids that incorporate choline as a headgroup. DMPC is applied in lipid bilayer studies and in biological systems. Synthetic dimyristoylphosphatidylcholine liposomes are used in various ways as safe drug carriers.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | VISUDYNE Approved UseVISUDYNE for injection is a photosensitizer indicated for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis. Launch Date2000 |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Phase separations in phospholipd membranes. | 1975 Feb 25 |
|
Physical properties of the dimyristoylphosphatidylcholine vesicle and of complexes formed by its interaction with apolipoprotein C-III. | 1977 May 17 |
|
Interaction of plasma high density lipoprotein HDL2b (d 1.063-1.100 g/ml) with single-bilayer liposomes of dimyristoylphosphatidylcholine. | 1978 Dec |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/11041265
678 mg/kg were administrated once each day for 13 days
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/10513636
IC50 of DMPC on the growth of B16 melanoma cells is about 0,5 mM.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
241349
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
1427050
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
4651
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
1362902
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
ALTERNATIVE | |||
|
DB11283
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
18656-38-7
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
45240
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
SUB20445
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
D004134
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
242-481-1
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
26197
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
U86ZGC74V5
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
U86ZGC74V5
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
100000085552
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY | |||
|
DTXSID4046816
Created by
admin on Fri Dec 15 19:00:09 GMT 2023 , Edited by admin on Fri Dec 15 19:00:09 GMT 2023
|
PRIMARY |
ACTIVE MOIETY